Conclusions The addition of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer.

• 结论：联合唑来膦酸的辅助性激素治疗提高绝经前雌激素敏感早期乳腺癌患者的无病存活率。